Deferred Tax Assets, Valuation Allowance of ORTHOPEDIATRICS CORP from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ORTHOPEDIATRICS CORP quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • ORTHOPEDIATRICS CORP Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $65,313,000, a 22% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ORTHOPEDIATRICS CORP Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $65,313,000 +$11,571,000 +22% 31 Dec 2025 10-K 04 Mar 2026 2025 FY
Q4 2024 $53,742,000 +$11,815,000 +28% 31 Dec 2024 10-K 04 Mar 2026 2025 FY
Q4 2023 $41,927,000 +$5,149,000 +14% 31 Dec 2023 10-K 05 Mar 2025 2024 FY
Q4 2022 $36,778,000 -$2,133,000 -5.5% 31 Dec 2022 10-K 08 Mar 2024 2023 FY
Q4 2021 $38,911,000 +$5,751,000 +17% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q4 2020 $33,160,000 +$7,768,000 +31% 31 Dec 2020 10-K 03 Mar 2022 2021 FY
Q4 2019 $25,392,000 +$1,071,000 +4.4% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q4 2018 $24,321,000 +$3,099,000 +15% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q4 2017 $21,222,000 -$8,364,000 -28% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q4 2016 $29,586,000 +$8,364,000 +39% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q4 2015 $21,222,000 31 Dec 2015 10-K 15 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.